Comparison of clinicopathological characteristics and survival outcomes between gallbladder mucinous adenocarcinoma and gallbladder adenocarcinoma: A propensity score-matched study

Figure 1 Flowchart of data selection of the gallbladder mucinous adenocarcinoma and typical gallbladder adenocarcinoma patients from the Surveillance, Epidemiology, and End Results database. GBMAC: Gallbladder mucinous adenocarcinoma; GBAC: Gallbladder adenocarcinoma.

Figure 2 Survival analysis of gallbladder mucinous adenocarcinoma and typical gallbladder adenocarcinoma patients. A: Overall survival (OS) for patients with gallbladder mucinous adenocarcinoma (GBMAC) and typical gallbladder adenocarcinoma (GBAC) in the unmatched cohort; B: Cancer-specific survival (CSS) for patients with GBMAC and typical GBAC in the unmatched cohort; C: OS for patients with GBMAC and typical GBAC in the propensity score matching (PSM) cohort; D: CSS for patients with GBMAC and typical GBAC in the PSM cohort. GBMAC: Gallbladder mucinous adenocarcinoma; GBAC: Gallbladder adenocarcinoma.

Figure 3 Cancer-specific survival changed with different variables in the gallbladder mucinous adenocarcinoma cohort. A: Cancer-specific survival (CSS) for gallbladder mucinous adenocarcinoma (GBMAC) patients < 60 years old and ≥ 60 years old; B: CSS for GBMAC patients according to sex; C: CSS for GBMAC patients according to race; D: CSS for GBMAC patients according to marital status; E: CSS for GBMAC patients according to histological grade; F: CSS for GBMAC patients with and without surgery; G: CSS for GBMAC patients with and without chemotherapy; H: CSS for GBMAC patients with and without radiotherapy; I: CSS for GBMAC patients according to American Joint Committee on Cancer stage; J: CSS for GBMAC patients according to T stage; K: CSS for GBMAC patients according to N stage; L: CSS for GBMAC patients according to M stage.